Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 13/20 | 0.65 |
| ▸ | LPL | P06858 | 12/20 | 0.65 |
| ▸ | P4HB | P07237 | 1/20 | 0.47 |
| ▸ | CA1 | P00915 | 2/20 | 0.42 |
| ▸ | CA2 | P00918 | 2/20 | 0.42 |
| ▸ | CA9 | Q16790 | 2/20 | 0.42 |
| ▸ | CA12 | O43570 | 1/20 | 0.42 |
| ▸ | CA3 | P07451 | 1/20 | 0.42 |
| ▸ | CA4 | P22748 | 1/20 | 0.42 |
| ▸ | CA6 | P23280 | 1/20 | 0.42 |
| ▸ | CA5A | P35218 | 1/20 | 0.42 |
| ▸ | CA7 | P43166 | 1/20 | 0.42 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.42 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.42 |
| ▸ | F11 | P03951 | 2/20 | 0.41 |
| ▸ | F2 | P00734 | 1/20 | 0.39 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.39 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.39 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.39 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL90476 | 0.82 | LIPG (0.76) | LIPGLPLP4HBCA1CA2 | |
| SCHEMBL19046610 | 0.82 | LIPG (0.76) | LIPGLPLP4HBCA1CA2 | |
| SCHEMBL10281613 | 0.81 | DGAT1 (0.63) | LIPGLPLCA1CA2CA9 | |
| SCHEMBL10281532 | 0.81 | CA1 (0.50) | LIPGLPLCA1CA2CA9 | |
| Ammonia Solution, Strong SCHEMBL4385797 | 0.80 | LIPG (0.73) | LIPGLPLP4HBCA1CA2 | |
| SCHEMBL228212 | 0.79 | LPL (0.71) | LIPGLPLP4HBCA1CA2 | |
| SCHEMBL10021061 | 0.79 | LIPG (1.00) | LIPGLPLP4HBCA1CA2 | |
| SCHEMBL476870 | 0.79 | LIPG (1.00) | LIPGLPLP4HBCA1CA2 | |
| SCHEMBL18270366 | 0.79 | LIPG (1.00) | LIPGLPLP4HBCA1CA2 | |
| SCHEMBL18134357 | 0.79 | LIPG (1.00) | LIPGLPLP4HBCA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10454034-B2 | Hexabenzocoronene-based compound for organic photovoltaic cells | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2019-10-22 | — | — | US | disclosed |
| US-20180047906-A1 | HEXABENZOCORONENE-BASED COMPOUND FOR ORGANIC PHOTOVOLTAIC CELLS | UNIVERSITE DE PAU ET DES PAYS DE L'ADOUR (FR) | 2018-02-15 | — | — | US | disclosed |
| US-20180047906-A1 | HEXABENZOCORONENE-BASED COMPOUND FOR ORGANIC PHOTOVOLTAIC CELLS | UNIVERSITE DE PAU ET DES PAYS DE L'ADOUR (FR) | 2018-02-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10454034-B2 | Hexabenzocoronene-based compound for organic photovoltaic cells | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, PPOX, PAX3 | LIPG 4063/4885LPL 4064/4885P4HB 208/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.